Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: pathologic complete response rate, predictive and prognostic factors

The purpose of this study was to retrospectively review the pathologic complete response (pCR) rate from patients (n=86) with stage II and III HER2-positive breast cancer treated with neoadjuvant chemotherapy at our institution from 2008 to 2013 and to determine possible predictive and prognostic fa...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	I.P.C. Buzatto, A. Ribeiro-Silva, J.M. Andrade, H.H.A. Carrara, W.A. Silveira, D.G. Tiezzi
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Associação Brasileira de Divulgação Científica
Seri Bilgileri:	Brazilian Journal of Medical and Biological Research
Konular:	Neoadjuvant chemotherapy Trastuzumab Pathologic complete response Predictive factors of response Prognosis
Online Erişim:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2017000200702&lng=en&tlng=en
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!